Ani Pharmaceuticals (ANIP) Change in Inventory (2012 - 2026)

Ani Pharmaceuticals (ANIP) has 15 years of Change in Inventory data on file, last reported at $437000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 30.08% year-over-year to $437000.0; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (down 70.04% YoY), and the FY2025 full-year result was $6.0 million, down 72.0% from the prior year.
• Change in Inventory advanced to $437000.0 in Q1 2026, from -$3.7 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $11.6 million in Q2 2024 to a low of -$3.7 million in Q4 2025.
• A 5-year average of $3.4 million and a median of $2.3 million in 2023 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory surged 1635.58% in 2024 and slumped 652.89% in 2025, its largest moves.
• Tracing ANIP's Change in Inventory over 5 years: stood at $9.5 million in 2022, then slumped by 51.33% to $4.6 million in 2023, then sank by 85.34% to $675000.0 in 2024, then tumbled by 652.89% to -$3.7 million in 2025, then surged by 111.71% to $437000.0 in 2026.
• Business Quant data shows ANIP's Change in Inventory at $437000.0 in Q1 2026, -$3.7 million in Q4 2025, and $8.2 million in Q3 2025.